Aim & Scope
Covid Research and Treatment (ISSN: 2836-3604) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines.
Covid Research and Treatment (ISSN: 2836-3604) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines.
Covid Research and Treatment (ISSN: 2836-3604) is an Open Access single blinded peer-reviewed medical journal, publish original research articles, review papers, clinical studies, case reports, editorials, and perspectives etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others.
Covid Research and Treatment (ISSN: 2836-3604) deals with the disorders and complications that are related to COVID-19, including viral infection mechanisms, respiratory and systemic complications, therapeutic interventions, vaccines, and emerging treatment strategies.
The current research in Covid Research and Treatment (ISSN: 2836-3604) involves in the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners and even for common people.
Covid Research and Treatment (ISSN: 2836-3604) accepts the articles in the fields of: General COVID-19 Research, SARS-CoV-2, COVID-19 Pandemic, Coronavirus Variants (Delta, Omicron, XBB), Epidemiology of COVID-19, Viral Pathogenesis, Host-Virus Interaction, COVID-19 Diagnostics, Asymptomatic COVID-19, Long COVID (Post-Acute Sequelae of SARS-CoV-2 Infection - PASC), Zoonotic Transmission of Coronaviruses, COVID-19 Diagnosis & Testing, RT-PCR Testing, Antigen Rapid Tests, Serological Antibody Testing, Viral Load Measurement, CRISPR-Based COVID-19 Tests, AI in COVID-19 Diagnosis, COVID-19 Imaging (CT, X-ray, MRI), COVID-19 Treatment Strategies, Antiviral Drugs (Remdesivir, Molnupiravir, Paxlovid), Monoclonal Antibodies (Casirivimab, Imdevimab), Corticosteroids (Dexamethasone), Immunomodulators (Tocilizumab, Baricitinib), Convalescent Plasma Therapy, mRNA-Based Therapies, Repurposed Drugs (Ivermectin, Hydroxychloroquine), COVID-19 Vaccines & Immunization, mRNA Vaccines (Pfizer-BioNTech, Moderna), Viral Vector Vaccines (AstraZeneca, Johnson & Johnson), Inactivated Vaccines (Sinopharm, Sinovac), Protein Subunit Vaccines (Novavax), Vaccine Efficacy & Safety, Booster Shots & Waning Immunity, Vaccine Hesitancy & Acceptance, Herd Immunity & COVID-19, Genomic Surveillance of SARS-CoV-2, Emerging & Future Research, AI & Big Data in COVID-19 Research.
Authors can contribute their valuable submission through online and/or to info@mediresonline.org
General COVID-19 Research: encompasses studies on the virus SARS-CoV-2, its transmission, pathogenesis, and impact on human health. Research includes vaccine development, antiviral treatments, diagnostics, and epidemiological studies. Findings guide public health measures, clinical management, and strategies to prevent future outbreaks.
Host-Virus Interaction: refers to the biological processes and mechanisms through which a virus infects, replicates, and interacts with its host organism. It includes viral entry, immune evasion, and host defense responses. Understanding these interactions is crucial for developing antiviral therapies and vaccines.
Long COVID: refers to a condition where individuals experience persistent symptoms weeks or months after recovering from acute COVID-19. Common symptoms include fatigue, shortness of breath, brain fog, and joint pain. Research focuses on understanding its causes, risk factors, and management strategies.
Antigen Rapid Tests: are diagnostic tests that quickly detect specific viral proteins (antigens) from pathogens like SARS-CoV-2. They provide results within minutes and are used for early detection of infections. While convenient, they are generally less sensitive than PCR tests, especially in asymptomatic individuals.
Viral Load Measurement: is the quantification of the amount of virus present in a patient’s blood or other body fluids. It helps assess infection severity, monitor treatment response, and guide clinical decisions. Regular viral load testing is crucial for managing diseases like HIV, hepatitis, and COVID-19.
Antiviral Drugs: are medications designed to treat viral infections by inhibiting viral replication or interfering with viral life cycles. They help reduce symptoms, shorten illness duration, and prevent complications. Antivirals are used for infections like influenza, HIV, hepatitis, and COVID-19.
mRNA Vaccines: are a type of vaccine that uses messenger RNA to instruct cells to produce a viral protein, triggering an immune response. They do not contain live virus and cannot cause the disease. mRNA vaccines have been used effectively against COVID-19 and are being explored for other infectious diseases and cancer.
Vaccine Efficacy & Safety: refers to evaluating how well a vaccine prevents infection or disease and its risk of adverse effects. Efficacy is measured in clinical trials, while safety is monitored during trials and post-licensure. Ensuring both is critical for public health and vaccine confidence.
Emerging & Future Research: refers to innovative and ongoing studies that explore new scientific questions, technologies, and therapies. It focuses on advancing knowledge, addressing unmet medical needs, and developing next-generation treatments. This research drives progress in healthcare, disease prevention, and personalized medicine.
COVID-19 Research: encompasses studies on the SARS-CoV-2 virus, its transmission, pathogenesis, and impact on human health. It includes vaccine development, antiviral treatments, diagnostics, and epidemiology. Research findings guide public health strategies, clinical management, and efforts to prevent future outbreaks.
